Application Nr Approved Date Route Status External Links
NDA209299 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Tavalisse Is Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Immune Thrombocytopenia (Itp) Who Have Had An Insufficient Response To A Previous Treatment. Tavalisse Is A Kinase Inhibitor Indicated For The Treatment Of Thrombocytopenia In Adult Patients With Chronic Immune Thrombocytopenia (Itp) Who Have Had An Insufficient Response To A Previous Treatment.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Fostamatinib FOSTAMATINIB ZINC43131420

Comments